ÃâÒßѧÊÔÌâ
v:d9o.h Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
?y-s20Kd 1. Fas(CD95)/FasL
MD'>jO;n 2. common chain of cytokine receptor
Z
g $Tf 3 . TCR/CD3 complex
^g!B.ll` 4. negaive selection of thymocytes
\f"?Tv-C
' 5. artificial active immune
,k*F`.[ 6. anti-idiotypic
!A[S6-18%- 7. IgSF
T"W9YpZ 8. Integrin
yDtOpM8<{ 9. chemokine
u7muaSy 10. B7/CD28
EUwQIA2c8N ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
aIu2> 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
R$xY8+}V 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
]p$zvMf} 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
K^
6+Ily 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
_0]QS4a][c
@"8~Y|L93 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
]<X2AO1 µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
X,Zd= Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
VR v02m5 1. B7/CD28
KW>VOW<. 2. Th1 subset
IHVMHOq}' 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
{]M>Y%j48 4. antibody affinity maturation
)l{A{f6O 5. AP-1
f+^c@0que 6. single chain variable fragment£¨ScFv£©
i+RD]QL 7. NK cell receptor
0s!N@ ,T 8. Zinkernagel-Doherty phenomenon
>p |yf.G 9. Ig fold
O*4gV }:G 10. CD40/CD40L
Gt5$6>A ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
/Tcb\:`9 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
N&N 82OG 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
7%YYr^d 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
sZEgsrJh Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
neIy~H_#! 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
Vs|sw 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
W60Q3 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
'XEK&Yi1 Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
?KCxrzf £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
{\lui eG Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
N[]U%9[=2F 1.Co-stimulators (or co-stimulating molecules)
w. vY(s 2.NK-kB
9Yd-m 3.Immunoglobulin superfamily
{ $X
X 4.antigen-presenting cell (APC)
LEA;dSf 5.death domain
GP Ix@k 6.CCR and CXCR
f{f_g8f[ 7.Lectin (or mitogen)
G+fd.~aGE 8.Clusters of differentiation, CD)
#,)PN @P 9.B7 family
G u6[{u 10.Cytotoxic T lymphocyte, CTL)
%OuX`w
= 11.IL-15 and IL-15 receptor (IL-15R)
*|@+rbjVC 12.MHC restriction
bD d_} 13.Affinity-chromatography
DqRLx85d1 14.Cyctosprin A, CsA
$e>/?Ss 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
QZ?O;K1|y ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
#i@ACAgn;6 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
FBYll[
8 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
vP-3j 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
uSH>$;a Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
_`slkwP. ÃâÒßѧרҵ£º
`!] R!T@C 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
0T 1HQ Ïû»¯ÄÚ¿Æ£º
ZK%Kgk[\:~ 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
;HR 6X ѪҺ²¡Ñ§×¨Òµ£º
YCir Oge 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
VfQMFb',o Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
Lhl$w'r (רҵ»ù´¡: ÃâÒßѧ)
fui4@ Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
|\i:LG1 1. ADCC(antibody dependent cell-mediated cytotoxicity)
#;wkr)) 2. »·æß¾úËØ(cyclosporin)
T@%;0Ro~ 3. KIR(killer cell inhibitory receptor)
c-[Q,c 4. HLDA(human leucocyte differentiation antigen)
MZ;"J82p 5. Interleukin 18(IL-18)
I{`KKui<M 6. ÕûºÏËØ(integrin)
@SKO~?7T 7. Fas/FasL
73&]En 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
#]5&mKi 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
V}vl
2o 10. Th1/Th2
ipx@pNW;" 11. »ùÒòÒßÃç(DNAÒßÃç)
?2JS&i 12. chemokines and chemokine receptor
u@GRN`yn 13. ÃâÒßÄÍÊÜ
*,O
:>Z5I 14. ¹²´Ì¼¤·Ö×Ó
r24\DvS 15. ËÀÍö½á¹¹Óò(death domain)
E9L!O.Q ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
pb=jvK 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
Zp/qs
z(] 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
7bgnZ]r8t £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
1TK #eU £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
j\XX:uU
_ £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
3EbnZb £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
W _PM!>8` 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
H]%mP| Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
U6/m_`nc ÎÊ´ðÌâ(ÿÌâ25·Ö)
vR6^n~ 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
?=/}Ft 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
k#8S`W8^ 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
_'?8s6 H 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£